Gaucher Disease Treatment Market is Highly Competitive and Dynamic with Major Key Players | Genzyme Corporation, Pfizer, Inc., Shire Human Genetics Therapies, Inc. – Digital Journal
A genetic metabolic disease known as Gaucher disease results in an inability to break down a particular form of fat (lipid) called glucocerebroside. Glucocerebroside is broken down and processed again by a body enzyme known as glucocerebrosidase. Gaucher disease is caused by mutations in the GBA gene, which result in very low levels of the …